These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24807344)

  • 1. When pregnancy must end in the second trimester.
    Goldberg AB
    Obstet Gynecol; 2014 Jun; 123(6):1153-1154. PubMed ID: 24807344
    [No Abstract]   [Full Text] [Related]  

  • 2. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
    Dickinson JE; Jennings BG; Doherty DA
    Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on the combination of mifepristone and misoprostol for the termination of second-trimester pregnancy.
    Chen YP; Wang PH; Tsui KH
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):469-70. PubMed ID: 26384078
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.
    Raymond EG; Grossman D; Mark A; Upadhyay UD; Dean G; Creinin MD; Coplon L; Perritt J; Atrio JM; Taylor D; Gold M
    Contraception; 2020 Jun; 101(6):361-366. PubMed ID: 32305289
    [No Abstract]   [Full Text] [Related]  

  • 5. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical guidance for termination of pregnancy at 8 to 16 weeks gestation with mifepristone and misoprostol].
    Chinese Society of Family Planning, Chinese Medical Association
    Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):321-2. PubMed ID: 26311448
    [No Abstract]   [Full Text] [Related]  

  • 8. Early medical abortion--available and safe.
    de Costa CM; Carrette M
    Med J Aust; 2012 Sep; 197(5):257-8. PubMed ID: 22938106
    [No Abstract]   [Full Text] [Related]  

  • 9. Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
    Bagga R; Sharma B; Choudhary N; Singla R; Saha PK; Bharati J; Rajkumar Kopp C; Jain S
    Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):171-173. PubMed ID: 33615941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
    Stibbe KJ; de Weerd S
    Arch Gynecol Obstet; 2012 Sep; 286(3):795-6. PubMed ID: 22434057
    [No Abstract]   [Full Text] [Related]  

  • 14. Misoprostol: life-saving.
    Faundes A
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):57-60. PubMed ID: 21417559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protocol to induce abortion using Mifepristone and Misoprostol].
    Andreeva A; Dimitrov J; Marinov B
    Akush Ginekol (Sofiia); 2015; 54(9):62-7. PubMed ID: 26863800
    [No Abstract]   [Full Text] [Related]  

  • 16. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?
    Shannon C; Winikoff B
    Womens Health (Lond); 2008 Mar; 4(2):107-11. PubMed ID: 19072508
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to misoprostol after mifepristone: still a bone of contention!
    Rajaram S; Mehta S; Goel N
    BJOG; 2011 Apr; 118(5):629; author reply 629-30. PubMed ID: 21392227
    [No Abstract]   [Full Text] [Related]  

  • 18. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
    Newhall EP; Winikoff B
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S44-53. PubMed ID: 10944369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of simultaneous use of mifepristone and misoprostol for early abortion.
    Li YT; Chen TH; Kuo TC
    Int J Gynaecol Obstet; 2008 Jun; 101(3):301. PubMed ID: 18289538
    [No Abstract]   [Full Text] [Related]  

  • 20. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.